Dihydromyricetin May Attenuate Skin Aging as a RAGE Inhibitor
Nutrients · 2025
DOI: 10.3390/nu17111862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Fei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Flavonols, Skin Aging, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nutrition Science Foundation of Chinese Nutrition Society.
Abstract (Originalsprache)
Background/Objectives: Dihydromyricetin (DHM), a flavonoid with abundant natural sources, potent bioactivity, and high safety, holds promise for translational applications, particularly in mitigating skin aging. However, its role and underlying mechanisms in counteracting skin aging induced by advanced glycation end products (AGEs) remain unclear.
Methods
Eight-week-old male Sprague-Dawley (SD) rats were subcutaneously injected with 500 mg/kg D-galactose and administered DHM via gavage for 11 weeks. Additionally, senescent human skin fibroblasts (HFF-1) induced by AGEs were used for further investigation.
Results
DHM treatment significantly alleviated D-galactose-induced skin aging in rats, with the most pronounced effects observed in the moderate-dose group (100 mg/kg). Compared to the aging group, DHM enhanced skin elasticity and preserved collagen levels. Moreover, DHM promoted cell proliferation in the skin. Further studies on AGE-induced senescent fibroblasts revealed that DHM markedly reduced multiple senescence-associated markers and stimulated cell proliferation by approximately a 1.5-fold increase. Transcriptomic analysis indicated that DHM upregulated genes related to the cell cycle and DNA repair while suppressing AGE-RAGE signaling and its downstream pathways. Notably, DHM downregulated AGER, the gene encoding the receptor for AGEs (RAGE). Molecular docking analysis demonstrated that DHM shares a binding site with other known RAGE inhibitors. Surface plasmon resonance (SPR) analysis further confirmed the high binding affinity of DHM to RAGE (KD = 28.7 μM), which was stronger and more stable than that of FPS-ZM1 (KD = 40.7 μM).
Conclusions
DHM may attenuate glycation-induced skin aging in rats by functioning as a RAGE inhibitor, thereby suppressing AGE-RAGE signaling, delaying cellular senescence, and promoting cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China.
- Jinan Municipal Center for Disease Control and Prevention, Jinan 250021, China.
- Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Peking University, Beijing 100191, China.
ORCID-Profile: Fei Wang, Liangchun Kuo, Junbo Wang
Förderung
- Nutrition Science Foundation of Chinese Nutrition Society
Zitieren
APA
Wang, F., Jian, Y., Xia, F., Kuo, L., & Wang, J. (2025). Dihydromyricetin May Attenuate Skin Aging as a RAGE Inhibitor. Nutrients. https://doi.org/10.3390/nu17111862
Vancouver
Wang F, Jian Y, Xia F, Kuo L, Wang J. Dihydromyricetin May Attenuate Skin Aging as a RAGE Inhibitor. Nutrients. 2025. doi:10.3390/nu17111862
BibTeX
@article{Wang2025,
author = {Wang, Fei and Jian, Yuanzhi and Xia, Fangzhi and Kuo, Liangchun and Wang, Junbo},
title = {Dihydromyricetin May Attenuate Skin Aging as a RAGE Inhibitor},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17111862}
}
EUVIMED